HYPERINTENSITY IN BRAIN DEEP NUCLEI

This adverse event was reported 84 times

These drugs are most commonly taken by patients reporting HYPERINTENSITY IN BRAIN DEEP NUCLEI:

# Drug Count
0 GADOBENATE DIMEGLUMINE 11
1 GADODIAMIDE 10
2 PREDNISONE 10
3 GADOTERIDOL 9
4 METRONIDAZOLE 8
5 METRONIDAZOLE TOPICAL 8
6 METHOTREXATE SODIUM 7
7 GADOTERATE MEGLUMINE 6
8 RITUXIMAB 6
9 BORTEZOMIB 5
See all common drugs associated with HYPERINTENSITY IN BRAIN DEEP NUCLEI

HYPERINTENSITY IN BRAIN DEEP NUCLEI is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GADOTERIDOL 9 0.0050
1 GADODIAMIDE 10 0.0030
2 GADOBENATE DIMEGLUMINE 11 0.0025
3 GADOTERATE MEGLUMINE 6 0.0016
4 CYCLOSERINE 1 0.0004
5 GADOBUTROL 2 0.0004
6 FAMCICLOVIR 1 0.0004
7 TENOFOVIR DISOPROXIL FUMARATE TABLETS 2 0.0002
8 PYRAZINAMIDE 2 0.0002
9 VIGABATRIN 3 0.0002
See all drugs enriched for association with HYPERINTENSITY IN BRAIN DEEP NUCLEI